Development and Validation of an LC-MS-MS Method for Determination of Simvastatin and Simvastatin Acid in Human Plasma: Application to a Pharmacokinetic Study

Journal of Chromatographic Science

Volumn 54, Issue 8, 2016, Pages 1385-1396

  Partani, Pankaj ^a   Verma, Saurabh Manaswita ^b   Monif, Tausif ^a  

^a Sun Pharmaceutical Industries Ltd   (India)

^b BIRLA INSTITUTE OF TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

SIMVASTATIN; SIMVASTATIN ACID;

ANALOGS AND DERIVATIVES; BLOOD; BLOOD ANALYSIS; HUMAN; LIQUID CHROMATOGRAPHY; PROCEDURES; REPRODUCIBILITY; STANDARDS; TANDEM MASS SPECTROMETRY; VALIDATION STUDY;

BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, LIQUID; HUMANS; REPRODUCIBILITY OF RESULTS; SIMVASTATIN; TANDEM MASS SPECTROMETRY;

EID: 84984982011     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/bmw087     Document Type: Article

References (27)

1. Todd, P., Goa, K.; Simvastatin: a review of its pharmacological properties and potential in hypercholesterolaemia; Drugs, (1990); 40: 583-607.
2. Duggan, D.E., Vickers, S.; Physiological disposition of HMG-CoA reductase inhibitors; Drug Metabolism Reviews, (1990); 22: 333-362.
3. Vickers, S., Duncan, C.A., Chen, I.W., Rosegay, A., Duggan, D.E.; Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug; Drug Metabolism and Disposition, (1990); 18: 138-145.
4. Williams, D., Feely, J.; Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors; Clinical Pharmacokinetics, (2002); 41: 343-370.
5. Neuvonen, P.J., Backman, J.T., Niemi, M.; Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin; Clinical Pharmacokinetics, (2008); 47: 463-474.
6. Mauro, V.F.; Clinical pharmacokinetics and practical applications of simvastatin; Clinical Pharmacokinetics, (1993); 24: 195-202.
7. Desager, J.P., Horsmans, Y.; Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors; Clinical Pharmacokinetics, (1996); 31: 348-371.
8. Wang, L., Asgharnejad, M.; Second-derivative UV spectrometric determination of simvastatin in its tablet dosage form; Journal of Pharmaceutical and Biomedical Analysis, (2000); 21: 1243-1248.
9. Carlucci, G., Mazzeo, P., Biordi, L., Bologna, M.; Simultaneous determination of simvastatin and its hydroxy acid form in human plasma by highperformance liquid chromatography with UV detection; Journal of Pharmaceutical and Biomedical Analysis, (1992); 10: 693-697.
10. Ochiai, H., Uchiyama, N., Imagaki, K., Hata, S., Kamei, T.; Determination of simvastatin and its active metabolite in human plasma by column-switching high-performance liquid chromatography with fluorescence detection after derivatization with 1-bromoacetylpyrene; Journal of Chromatography B, (1997); 694: 211-217.
11. Takano, T., Abe, S., Hata, S.; A selected ion monitoring method for quantifying simvastatin and its acid form in human plasma, using the ferrocene boronate derivative; Biomedical & Environmental Mass Spectrometry, (1990); 19: 577-581.
12. Morris, M.J., Gilbert, J.D., Hsiehm, J.Y., Matuszewski, B.K., Ramjit, H.G., Bayne,W.F.; Determination of the HMG-CoA reductase inhibitors simvastatin, lovastatin, and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometry; Biological Mass Spectrometry, (1993); 22: 1-8.
13. Yang, H., Feng, Y., Luan, Y.; Determination of Simvastatin in human plasma by liquid chromatography-mass spectrometry; Journal of Chromatography B, (2003); 785: 369-375.
14. Jemal, M., Ouyang, Z., Powell, M.L.; Direct-injection LC-MS-MS method for high-throughput simultaneous quantitation of simvastatin and simvastatin acid in human plasma; Journal of Pharmaceutical and Biomedical Analysis, (2000); 23: 323-340.
15. Zhao, J.J., Xie, I.H., Yang, A.Y., Roadcap, B.A., Rogers, J.D.; Quantitation of simvastatin and its beta-hydroxy acid in human plasma by liquid-liquid cartridge extraction and liquid chromatography/tandem mass spectrometry; Journal of Mass Spectrometry, (2000); 35: 1133-1143.
16. Zhang, N., Yang, A., Rogers, J.D., Zhao, J.J.; Quantitative analysis of simvastatin and its beta-hydroxy acid in human plasma using automated liquid-liquid extraction based on 96-well plate format and liquid chromatography-tandem mass spectrometry; Journal of Pharmaceutical and Biomedical Analysis, (2004); 34; 175-187.
17. Yang, A.Y., Sun, L., Musson, D.G., Zhao, J.J.; Application of a novel ultra-low elution volume 96-well solid-phase extraction method to the LC/MS/MS determination of simvastatin and simvastatin acid in human plasma; Journal of Pharmaceutical and Biomedical Analysis, (2005); 38: 521-527.
18. Barrett, B., Huclová, J., Borek-Dohalský, V., Nemec, B., Jelínek, I.; Validated HPLC-MS/MS method for simultaneous determination of simvastatin and simvastatin hydroxy acid in human plasma; Journal of Pharmaceutical and Biomedical Analysis, (2006); 41: 517-526.
19. Apostolou, C., Kousoulos, C., Dotsikas, Y., Soumelas, G.S., Kolocouri, F., Ziaka, A., et al.; An improved and fully validated LC-MS/MS method for the simultaneous quantification of simvastatin and simvastatin acid in human plasma; Journal of Pharmaceutical and Biomedical Analysis, (2008); 46: 771-779.
20. Patel, B.N., Sharma, N., Sanyal, M., Shrivastav, P.S.; Simultaneous determination of simvastatin and simvastatin acid in human plasma by LC-MS/MS without polarity switch: application to a bioequivalence study; Journal of Separation Science, (2008); 31: 301-313.
21. Ahmed, T.A.,Horn, J., Hayslip, J., Leggas, M.; Validated LC-MS/MS method for simultaneous determination of SIM and its acid forms in human plasma and cell lysate: Pharmacokinetic application; Journal of Pharmaceutical Analysis, (2012); 2: 403-411.
22. Prueksaritanont, T., Subramanian, R., Fang, X., Ma, B., Qiu, Y., Lin, J.H., et al.; Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization; Drug Metabolism and Disposition, (2002); 30: 505-512.
23. Fura, A., Harper, T.W., Zhang, H., Fung, L., Shyu, W.C.; Shift in pH of biological fluids during storage and processing: effect on bioanalysis; Journal of Pharmaceutical and Biomedical Analysis, (2003); 32: 513-522.
24. Guidance for industry: bioanalytical method validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD, 2001. http://www.fda. gov/CVM.
25. Matuszewski, B.K., Constanzer, M.L., Chavez-Eng, C.M.; Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS-MS; Analytical Chemistry, (2003); 75: 3019-3030.
26. Viswanathan, C.T., Bansal, S., Booth, B., DeStefano, A.J., Rose, M.J., Sailstad, J., et al.; Workshop/conference report-quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays; The AAPS Journal, (2007); 9: E30-E42.
27. Alexander, A.J.,Waeghe, T.J., Himes, K.W., Tomasella, F.P., Hooker, T.F.; Modifying conventional high-performance liquid chromatography systems to achieve fast separations with fused-core columns: a case study; Journal of Chromatography A, (2011); 1218: 5456-5469.